EARTH LIFE SCIENCES INC
CLTSDrugs in Pipeline
6
Phase 3 Programs
3
Upcoming Catalysts
1
Next Catalyst
This month
Market Overview
Stock performance and key metrics
1 upcoming, 0 past
rhPSMA-7.3 (18F) Injection
Prostate Cancer
18F fluciclovine
Brain Metastases
18F-Fluciclovine PET CT
Cancer of the Prostate
[18F]FPyQCP
Colorectal Cancer
Lutetium (177Lu) rhPSMA-10.1 Injection
Prostate Cancer
[68Ga]BED003
Colorectal Cancer
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
rhPSMA-7.3 (18F) Injection | Phase 3 | Prostate Cancer | - | - |
18F fluciclovine | Phase 3 | Brain Metastases | - | - |
18F-Fluciclovine PET CT | Phase 3 | Cancer of the Prostate | - | - |
[18F]FPyQCP | Phase 2 | Colorectal Cancer | - | - |
Lutetium (177Lu) rhPSMA-10.1 Injection | Phase 2 | Prostate Cancer | - | - |
[68Ga]BED003 | Phase 2 | Colorectal Cancer | - | - |
Source: CatalystAlert database (ClinicalTrials.gov, SEC EDGAR)
Full breakdown — the signals behind the verdict
Frequently asked questions
What is in EARTH LIFE SCIENCES INC's drug pipeline?→
CatalystAlert tracks 6 drug candidates in EARTH LIFE SCIENCES INC's (CLTS) pipeline across Phase 3, Phase 2. Its lead program is rhPSMA-7.3 (18F) Injection (Phase 3). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is EARTH LIFE SCIENCES INC's next FDA catalyst?→
EARTH LIFE SCIENCES INC's (CLTS) next tracked catalyst is a Phase 2 expected August 27, 2026. See the catalyst timeline on this page for the full schedule of PDUFA dates, trial readouts and FDA events.
How do I track CLTS biotech catalysts?→
Add CLTS to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow EARTH LIFE SCIENCES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page — sourced from ClinicalTrials.gov, FDA and SEC filings.